» Articles » PMID: 37095919

/MicroRNA-34 Axis in Cancer and Beyond

Overview
Journal Heliyon
Specialty Social Sciences
Date 2023 Apr 25
PMID 37095919
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer is serious endangers human life. After a long period of research and accumulation, people's understanding of cancer and the corresponding treatment methods are constantly developing. is an important tumor suppressor gene. With the more in-depth understanding of the structure and function of , the more importance of this tumor suppressor gene is realized in the process of inhibiting tumor formation. MicroRNAs (miRNAs) are important regulatory molecules with a length of about 22nucleotides (nt), which belong to non-coding RNA and play an important role in the occurrence and development of tumors. miR-34 is currently considered to be a master regulator of tumor suppression. The positive feedback regulatory network formed by and miR-34 can inhibit the growth and metastasis of tumor cells and inhibit tumor stem cells. This review focuses on the latest progress of 3/miR-34 regulatory network, and discusses its application in tumor diagnosis and treatment.

Citing Articles

Regulates Muscle Growth and Development by Targeting .

Wu Y, Liu X, Fan Y, Zuo H, Niu X, Zuo B Cells. 2025; 14(5).

PMID: 40072107 PMC: 11898696. DOI: 10.3390/cells14050379.


Novel Detection and Clinical Utility of Serum-Derived Extracellular Vesicle in Angiosarcoma.

Yokoi K, Wang J, Yoshioka Y, Fujisawa Y, Fujimoto M, Ochiya T Acta Derm Venereol. 2025; 105:adv40902.

PMID: 40001341 PMC: 11877856. DOI: 10.2340/actadv.v105.40902.


A Critical Review on microRNAs as Prognostic Biomarkers in Laryngeal Carcinoma.

Komitova K, Dimitrov L, Stancheva G, Kyurkchiyan S, Petkova V, Dimitrov S Int J Mol Sci. 2025; 25(24.

PMID: 39769234 PMC: 11676902. DOI: 10.3390/ijms252413468.


Decoding the Promise and Challenges of miRNA-Based Cancer Therapies: An Essential Update on miR-21, miR-34, and miR-155.

Qian H, Maghsoudloo M, Jabbarzadeh Kaboli P, Babaeizad A, Cui Y, Fu J Int J Med Sci. 2024; 21(14):2781-2798.

PMID: 39512697 PMC: 11539376. DOI: 10.7150/ijms.102123.


The role of p53 in male infertility.

Li J, Huang X, Luo L, Sun J, Guo Q, Yang X Front Endocrinol (Lausanne). 2024; 15:1457985.

PMID: 39469578 PMC: 11513281. DOI: 10.3389/fendo.2024.1457985.


References
1.
Jansson K, Tucker J, Stahl L, Simmons J, Fuller C, Beshiri M . High-throughput screens identify HSP90 inhibitors as potent therapeutics that target inter-related growth and survival pathways in advanced prostate cancer. Sci Rep. 2018; 8(1):17239. PMC: 6250716. DOI: 10.1038/s41598-018-35417-0. View

2.
Akbar R, Ullah K, Ur Rahman T, Cheng Y, Pang H, Jin L . miR-183-5p regulates uterine receptivity and enhances embryo implantation. J Mol Endocrinol. 2019; 64(1):43-52. DOI: 10.1530/JME-19-0184. View

3.
Lam-Ubol A, Fitzgerald A, Ritdej A, Phonyiam T, Zhang H, Myers J . Sensory acceptable equivalent doses of β-phenylethyl isothiocyanate (PEITC) induce cell cycle arrest and retard the growth of p53 mutated oral cancer in vitro and in vivo. Food Funct. 2018; 9(7):3640-3656. DOI: 10.1039/c8fo00865e. View

4.
Shree B, Sengar S, Tripathi S, Sharma V . LINC01711 promotes transforming growth factor-beta (TGF-β) induced invasion in glioblastoma multiforme (GBM) by acting as a competing endogenous RNA for miR-34a and promoting ZEB1 expression. Neurosci Lett. 2022; 792:136937. DOI: 10.1016/j.neulet.2022.136937. View

5.
Li F, Li X, Qiao L, Liu W, Xu C, Wang X . MALAT1 regulates miR-34a expression in melanoma cells. Cell Death Dis. 2019; 10(6):389. PMC: 6525244. DOI: 10.1038/s41419-019-1620-3. View